Leinfelden-Echterdingen, Germany

Andreas Peschel


 

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: The Innovations of Andreas Peschel

Introduction

Andreas Peschel is a notable inventor based in Leinfelden-Echterdingen, Germany. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-infective compounds. With a total of two patents to his name, his work focuses on innovative solutions for treating infectious diseases.

Latest Patents

Peschel's latest patents revolve around novel infective agents. These inventions relate to the production of pharmaceutical compositions aimed at treating and preventing diseases, especially infectious ones. His work includes a pharmaceutical composition that comprises these compounds and methods for producing them. Additionally, he has developed a new probiotic designed to prevent or reduce the colonization of pathogenic microorganisms in the organs of living beings.

Career Highlights

Throughout his career, Andreas Peschel has worked with esteemed institutions such as Eberhard Karls Universität Tübingen. His research and innovations have contributed to advancements in the pharmaceutical industry, particularly in combating infectious diseases.

Collaborations

Peschel has collaborated with notable colleagues, including Bernhard Krismer and Stephanie Grond. These partnerships have further enhanced his research and development efforts in the field of anti-infective compounds.

Conclusion

Andreas Peschel's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight his commitment to advancing medical science. His work continues to impact the treatment of infectious diseases, showcasing the importance of innovation in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…